Researchers used the official ICD-10 diagnostic code, U09.9, for post-COVID-19 conditions that became effective Oct. 1, making them one of the first to do so. They analyzed private claims data from 78,252 patients diagnosed with the code from Oct. 1, 2021, to Jan. 31.
Three key findings:
- People ages 36-50 were the most likely to be diagnosed with post-COVID-19 conditions, as 34.6 percent of patients were in that age group.
- Women were more likely than men to be diagnosed with post-COVID-19 conditions.
- Of the patients presenting a post-COVID-19 condition, 30.7 percent had no identified preexisting chronic conditions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
